Optomed
3.485
EUR
-0.43 %
5,449 following
OPTOMED
NASDAQ Helsinki
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Investor consensus
-0.43%
-10.76%
-20.34%
-25.21%
-17.61%
-16.63%
-38.64%
-20.34%
-23.91%
Optomed is a medical technology company. The company conducts research and development of specialized eye cameras. Development takes place of both hardware and software that is resold under different brands. The company operates worldwide, with the largest presence in the Nordic market. The customers consist of research institutes and hospitals. Optomed is headquartered in Oulu.
Read moreMarket cap
68.63M EUR
Turnover
34.15K EUR
P/E (adj.) (25e)
-13.54
EV/EBIT (adj.) (25e)
-14.28
P/B (25e)
3.6
EV/S (25e)
3.87
Dividend yield-% (25e)
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
6/5
2025
Interim report Q1'25
7/8
2025
Interim report Q2'25
6/11
2025
Interim report Q3'25
Risk
Business risk
Valuation risk
Low
High
All
Research
Webcasts
Press releases
Optomed Oyj: NOTICE OF THE ANNUAL GENERAL MEETING OF OPTOMED PLC
Optomed Oyj: Optomed Annual Report 2024 published
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Redeye: Optomed Q4 - Quarter in line with expectations
Optomed Oyj: Optomed Plc: Financial Statements Bulletin, January - December 2024
Optomed Oyj: Proposal of Optomed's Nomination Board
